Oral Oxytocin's Effects on Attention Control: An Eye-tracking Study
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- Effect of oral oxytocin administration on saccade/antisaccade latencies towards social (facial) versus non-social (shape) stimuli
研究概览
简要总结
The main aim of the study is to investigate whether orally administered oxytocin (24IU) could modulate attention control using a social-emotional saccade/antisaccade eye-tracking paradigm.
详细描述
Numerous studies have reported the effect of intranasally administered oxytocin on attentional processing including stimulus-driven bottom-up processing and top-down goal-directed inhibitory control. However, it is unclear whether the functional effects are mediated by the peptide directly entering the brain or indirectly via raising peripheral concentrations. One possible method of producing a similar pattern of increased peripheral oxytocin concentrations but without the possibility of direct entry into the brain would be to administer the peptide lingually. In the present double-blind, between-subject, placebo-controlled study, 80 healthy male subjects will be recruited and receive either oxytocin (24IU) or placebo control administered orally (lingual). 45 minutes after treatment subjects are required to complete a social-emotional saccade/antisaccade eye-tracking paradigm. This paradigm uses social (happy, sad, angry, fear, and neutral faces) as well as non-social (oval shapes) stimuli to explore social- and emotion-specific effects of orally administered oxytocin.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Basic Science
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 30 Years(Adult)
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Male, healthy participants
- •Non smokers
排除标准
- •Previous or current medical, psychiatric, neurological disorder
- •Regular medication
- •Use of any psychoactive substances in the 24 hours before experiment
- •Contra-indications for oxytocin
- •Contra-indications for eye-tracking data acquisition
研究组 & 干预措施
Oral Placebo
Placebo orally (24 IU, identical ingredients, except the active agent)
干预措施: Oral Placebo (Drug)
Oral Oxytocin
Oxytocin orally (24 IU)
干预措施: Oral Oxytocin (Drug)
结局指标
主要结局
Effect of oral oxytocin administration on saccade/antisaccade latencies towards social (facial) versus non-social (shape) stimuli
时间窗: 45 minutes - 100 minutes after treatment
Comparison between social-specific saccade/antisaccade latencies (in milliseconds) between the oxytocin and placebo treatment conditions
Effect of oral oxytocin administration on error rates of saccade/antisaccade for social (facial) versus non-social (shape) stimuli
时间窗: 45 minutes - 100 minutes after treatment
Comparison between social-specific error rates of saccade/antisaccade between the oxytocin and placebo treatment conditions.
次要结局
- Emotion-specific effects of oral oxytocin administration on saccade/antisaccade latencies towards the separate facial emotions(45 minutes - 100 minutes after treatment)
- Emotion-specific effects of oral oxytocin administration on saccade/antisaccade error rates for the separate facial emotions(45 minutes - 100 minutes after treatment)
研究者
Keith Kendrick
Professor
University of Electronic Science and Technology of China
